As the tumor and normal CD19+ B cells were eliminated, transcriptional signatures of CAR-T cell activation and proliferation progressively declined without enrichment of an exhaustion gene signature or an increase in co-expression of inhibitory receptors at later times after infusion. Here, CD19 is linked to neoplasm.